1. Home
  2. EFSI vs KRRO Comparison

EFSI vs KRRO Comparison

Compare EFSI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$39.70

Market Cap

185.5M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.05

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSI
KRRO
Founded
1881
2014
Country
United States
United States
Employees
231
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.5M
150.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EFSI
KRRO
Price
$39.70
$13.05
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$41.50
$34.80
AVG Volume (30 Days)
16.6K
114.0K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
$31.93
N/A
Revenue Next Year
$4.38
N/A
P/E Ratio
$24.38
N/A
Revenue Growth
N/A
181.46
52 Week Low
$28.70
$5.20
52 Week High
$41.12
$55.89

Technical Indicators

Market Signals
Indicator
EFSI
KRRO
Relative Strength Index (RSI) 62.85 58.48
Support Level $38.38 $9.51
Resistance Level $41.06 $14.52
Average True Range (ATR) 0.86 0.95
MACD 0.21 0.32
Stochastic Oscillator 76.33 85.42

Price Performance

Historical Comparison
EFSI
KRRO

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: